Gastrointestinal Drugs Market 2027 By Propulsion Type, Power Type, Vehicle Type and Geography | The Insight Partners

Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, Others); Route of Administration (Oral, Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography

Publication Month: Oct 2020 | Report Code: TIPRE00014758 | No. of Pages: 209 | Category: Pharmaceuticals | Status: Published
Covid

The gastrointestinal drugs market was valued at US$ 49,043.38 million in 2019 and is projected to reach US$ 71,300.28million by 2027; it is expected to grow at a CAGR of4.9% from 2020to 2027.

 

Gastrointestinal (GI) disorders are the medical conditions related to the digestive system that affect the colon, small and large intestine, and rectum. The disorders include constipation, irritable bowel, ulcerative colitis, and peptic ulcer diseases. These disorders are characterized by various symptoms, such as pain, bloating, diarrhea, nausea, and vomiting. These disorders constitute a large proportion of outpatients and frequent hospital visits globally. A wide range of GI drugs is commercially available in the market for the treatment of various conditions. Additionally, rise in investments in the development of biologics and emergence of biosimilars are expected to drive the growth of the market in the forecast period.

                                       

The scope of the gastrointestinal drugs market includes drug class, route of administration, application, distribution channel, and region. The market for gastrointestinal drugs is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the gastrointestinal drugs market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.


Lucrative Regions for Gastrointestinal Drugs Market

Lucrative Regions for Gastrointestinal Drugs Market

Get more information on this report :


 

Market Insights

Rise in Prevalence of Gastrointestinal (GI) Diseases

Gastrointestinal diseases are the conditions that occur in the gastrointestinal tract. Common digestive problems include heartburn, inflammatory bowel diseases (IBD), inflammatory bowel syndrome (IBS), constipation, and diarrhea. GI diseases account for substantial health care utilization and spending. According to the European Federation of Crohn's & Ulcerative Colitis Associations (EFCCA), around 10 million people are living with IBD worldwide. Growing prevalence of IBD can be ascribed to poor nutritional choices, including a high intake of ultra-processed foods and trans-fats.

Western countries, such as the US, Canada, and the UK, are witnessing a high GI incidence rate due to increasing obesity in the adult population and less consumption of dietary fibers. As per the Centers for Disease Control and Prevention, in 2018, the number of visits to physician offices with the digestive system's diseases as the primary diagnosis was 22.4 million in the US. The incidence and prevalence of GI disorders are higher in the adult and elderly population. As the population ages, the disease burden is expected to increase. The GI disorders, such as inflammatory bowel diseases, Crohn’s disease, and ulcerative colitis, are common, chronic inflammatory conditions that affect a vast population worldwide. This is due to a sedentary lifestyle, changing dietary habits, stress, and other factors. The incidence and prevalence of IBS have increased in the last few decades worldwide. As per the International Foundation for Gastrointestinal Disorders, Inc., IBS is the most common functional GI disorder with a prevalence rate of 10–15% globally. Also, it is one of the most common conditions for a visit to a doctor. There are around 2.4–3.5 million physician visits for IBS annually in the US. The cost of direct medical expenses and indirect costs associated with loss of productivity and work absenteeism due to IBS is estimated to be around US$ 21 billion annually.

Moreover, in the last few years, the cases of IBD have increased worldwide. IBD is a chronic inflammation of the digestive tract and is of two types: Ulcerative colitis and Crohn's disease. As per the Crohn’s & Colitis Foundation of America, IBD affects approximately 1.6 million Americans. Around 70,000 new cases of IBD are diagnosed every year in the US. Apart from the US, Europe is also witnessing increasing burden of chronic digestive diseases due to the aging population and lifestyle factors such as rising obesity and heavy alcohol consumption. For instance, as per the EFCCA, around 3.4 million people in Europe are living with IBD. Thus, the factors mentioned above are driving the adoption of GI drugs during the forecast period.

 

Drug Class-BasedInsights                                    

Based on drug class, the gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others. In 2019, the acid neutralizerssegment accounted for the highest share of the market. Growth of this segment is attributed to increasing incidence of GERD and rising patient pool across the globe. However, the biologicssegment likely to register the highest CAGR in the global gastrointestinal drugsmarket during the forecast period.

                                                                                                       

Global Gastrointestinal Drugs Market, by Drug Class– 2019& 2027

Global Gastrointestinal Drugs Market, by Drug Class– 2019& 2027

Get more information on this report :


 

Route of Administration-Based Insights

In terms ofroute of administration, the gastrointestinal drugsmarket is segmented into oral and parenteral. The oral segment held the largest share of the market in 2019, whereas the same segment is estimated to register the highest CAGR of 5.2% in the market during the forecast period.

 

Application-BasedInsights

Based on application, the gastrointestinal drugsmarket is segmented into inflammatory ulcerative colitis, Crohn's disease, irritable bowel syndrome, gastroenteritis, celiac disease, and others. The inflammatory ulcerative colitissegment held the largest share of the market in 2019, whereas the irritable bowel syndromesegment is projected to register the highest CAGR of 5.8% in the market during the forecast period.

 

Distribution Channel-Based Insights

In terms ofdistribution channel, the gastrointestinal drugsmarket is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmaciessegment held the largest share of the market in 2019, and same segment is expected to register the highest CAGR of 5.4% in the market during the forecast period.                                                                                       

 

Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategiesare commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the gastrointestinal drugs market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

By Drug Class

  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
  • Others


By Route of Administration                          

  • Oral
  • Parenteral

 

By Application

  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
  • Others


By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

 

Company Profiles

  • Sanofi
  • GlaxoSmithKline plc
  • Johnson and Johnson Services, Inc.
  • Bausch Health
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
  • AbbVie Inc.
  • Bayer AG
  • Celltrion Healthcare Co., Ltd.
  • LEXICON PHARMACEUTICALS, INC

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Gastrointestinal Drugs Market – By Drug Class

1.3.2        Gastrointestinal Drugs Market – By Route of Administration

1.3.3        Gastrointestinal Drugs Market – By Application

1.3.4        Gastrointestinal Drugs Market – By Distribution Channel

1.3.5        Global Gastrointestinal Drugs Market – By Geography

2.             Gastrointestinal Drugs Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Gastrointestinal Drugs– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             Gastrointestinal Drugs Market– Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Rise in Prevalence of Gastrointestinal (GI) Diseases

5.1.2        Increase in Development of Biologics

5.2       Market Restraints

5.2.1        Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies

5.3       Market Opportunities

5.3.1        Increasing Investment in Research Activities and Growing Pipeline of GI Candidates

5.4       Future Trends

5.4.1        Emergence of Biosimilars

5.5       Impact Analysis

6.             Gastrointestinal Drugs Market – Global Analysis

6.1       Global Gastrointestinal Drugs Marker Revenue Forecast And Analysis

6.2       Global Gastrointestinal Drugs Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Gastrointestinal Drugs Market Analysis – By Drug Class

7.1       Overview

7.2       Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)

7.3       Acid Neutralizers

7.3.1        Overview

7.3.2        Acid Neutralizers: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.4       Antidiarrheal and Laxatives

7.4.1        Overview

7.4.2        Antidiarrheal and Laxatives: Gastrointestinal Drugs Market – Revenue and Forecast to 2027  (US$ Million)

7.5       Anti-Inflammatory Drugs

7.5.1        Overview

7.5.2        Anti-Inflammatory Drugs: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.6       Antiemetic and Antinauseants

7.6.1        Overview

7.6.2        Antiemetic and Antinauseants: Gastrointestinal Drugs Market – Revenue and Forecast to 2027  (US$ Million)

7.7       Biologics

7.7.1        Overview

7.7.2        Biologics: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

7.8       Others

7.8.1        Overview

7.8.2        Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

8.             Gastrointestinal Drugs Market Analysis – By Route of Administration

8.1       Overview

8.2       Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027

8.3       Oral

8.3.1        Overview

8.3.2        Oral: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

8.4       Parenteral

8.4.1        Overview

8.4.2        Parenteral: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.             Gastrointestinal Drugs Market Analysis – By Application

9.1       Overview

9.2       Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)

9.3       Inflammatory Ulcerative Colitis

9.3.1        Overview

9.3.2        Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market – Revenue and Forecast to 2027  (US$ Million)

9.4       Crohn's Disease

9.4.1        Overview

9.4.2        Crohn's Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Irritable Bowel Syndrome

9.5.1        Overview

9.5.2        Irritable Bowel Syndrome: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.6       Gastroenteritis

9.6.1        Overview

9.6.2        Gastroenteritis: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.7       Celiac Disease

9.7.1        Overview

9.7.2        Celiac Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

9.8       Others

9.8.1        Overview

9.8.2        Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10.          Gastrointestinal Drugs Market Analysis – By Distribution Channel

10.1    Overview

10.2    Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027

10.3    Hospital Pharmacies

10.3.1     Overview

10.3.2     Hospital Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10.4    Retail Pharmacies

10.4.1     Overview

10.4.2     Retail Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

10.5    Online Pharmacies

10.5.1     Overview

10.5.2     Online Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

11.          Gastrointestinal Drugs Market Analysis And Forecast To 2027 – Geographical Analysis

11.1    North America: Gastrointestinal Drugs Market

11.1.1     Overview

11.1.2     North America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.3     North America: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.4     North America: Gastrointestinal Drugs Market, by Route of Administration, 2018–2027 (USD Million)

11.1.5     North America: Gastrointestinal Drugs Market, by Application, 2018–2027 (USD Million)

11.1.6     North America: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.7     North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

11.1.8     US: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1    US: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2    US: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.8.3    US: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.8.4    US: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.8.5    US: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.9     Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1    Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2    Canada: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.9.3    Canada: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.9.4    Canada: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.9.5    Canada: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.1.10   Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.1.10.3 Mexico: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.1.10.4 Mexico: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.1.10.5 Mexico: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2    Europe: Gastrointestinal Drugs Market

11.2.1     Overview

11.2.2     Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)

11.2.3     Europe: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.4     Europe: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.5     Europe: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.6     Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2.7     Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)

11.2.8     Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.8.1    Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.8.2    Germany: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.8.3    Germany: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.8.4    Germany: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.8.5    Germany: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2.9     UK: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.9.1    UK: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.9.2    UK: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.9.3    UK: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.9.4    UK: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.9.5    UK: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2.10   France: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.10.1 France: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.10.2 France: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.10.3 France: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.10.4 France: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.10.5 France: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2.11   Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.11.1 Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.11.2 Spain: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.11.3 Spain: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.11.4 Spain: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.11.5 Spain: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2.12   Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.1 Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.12.2 Italy: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.12.3 Italy: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.12.4 Italy: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.12.5 Italy: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.2.13   Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.13.1 Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.2.13.2 Rest of Europe: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.2.13.3 Rest of Europe: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.2.13.4 Rest of Europe: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.2.13.5 Rest of Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3    Asia Pacific: Gastrointestinal Drugs Market

11.3.1     Overview

11.3.2     Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)

11.3.3     Asia Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.4     Asia Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.5     Asia Pacific: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.6     Asia Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3.7     Asia Pacific: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)

11.3.8     China: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.8.1    China: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.8.2    China: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.8.3    China: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.8.4    China: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.8.5    China: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3.9     Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.1    Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.9.2    Japan: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.9.3    Japan: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.9.4    Japan: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.9.5    Japan: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3.10   India: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.1 India: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.10.2 India: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.10.3 India: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.10.4 India: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.10.5 India: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3.11   South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.1 South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.11.2 South Korea: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.11.3 South Korea: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.11.4 South Korea: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.11.5 South Korea: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3.12   Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.1 Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.12.2 Australia: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.12.3 Australia: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.12.4 Australia: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.12.5 Australia: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.3.13   Rest of Asia-Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.13.1 Rest of Asia-Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.3.13.2 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018–2027 (USD Million)

11.3.13.3 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018–2027 (USD Million)

11.3.13.4 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Application 2018–2027 (USD Million)

11.3.13.5 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018–2027 (USD Million)

11.4    Middle East & Africa: Gastrointestinal Drugs Market

11.4.1     Overview

11.4.2     Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)

11.4.2.1    Middle East & Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.4.2.2    Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.4.2.3    Middle East & Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.4.2.4    Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.4.3     Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

11.4.3.1    Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.4.3.1.1    Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.4.3.2    Saudi Arabia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.4.3.3    Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.4.3.4    Saudi Arabia Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.4.3.5    Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

11.4.3.6    UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.4.3.6.1    UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.4.3.7    UAE Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.4.3.8    UAE Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.4.3.9    UAE Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.4.3.10 UAE Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.5    South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

11.5.1     South Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)

11.5.1.1    South Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.5.1.2    South Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

11.5.1.3    South Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.5.1.4    South Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.6    Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

11.6.1     Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)

11.6.1.1    Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027  (USD Million)

11.6.1.2    Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.6.1.3    Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.6.1.4    Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.7    South and Central America: Gastrointestinal Drugs Market

11.7.1     Overview

11.7.2     South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)

11.7.3     South and Central America: Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.7.4     South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.7.5     South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.7.6     South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.7.7     South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

11.7.8     Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.7.8.1    Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.7.8.2    Brazil: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

11.7.8.3    Brazil: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.7.8.4    Brazil: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.7.8.5    Brazil: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.7.9     Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.7.9.1    Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.7.9.2    Argentina: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

11.7.9.3    Argentina: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

11.7.9.4    Argentina: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.7.9.5    Argentina: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.7.10   Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027  (USD Million)

11.7.10.1 Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.7.10.2 Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

11.7.10.3 Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.7.10.4 Rest of South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.7.10.5 Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12.          Impact of COVID-19 Pandemic on Global Gastrointestinal Drugs Market

12.1    North America: Impact Assessment of COVID-19 Pandemic

12.2    Europe: Impact Assessment of COVID-19 Pandemic

12.3    Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

13.          Gastrointestinal Drugs Market–Industry Landscape

13.1    Overview

13.2    Growth Strategies Done by the Companies in the Market, (%)

13.3    Organic Developments

13.3.1     Overview

13.4    Inorganic Developments

13.4.1     Overview

14.          Company Profiles

14.1    Sanofi

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2    GlaxoSmithKline plc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3    Johnson and Johnson Services, Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4    Bausch Health

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5    AstraZeneca

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6    Takeda Pharmaceutical Company Limited

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7    AbbVie Inc.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8    Bayer AG

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9    Celltrion Healthcare Co.,Ltd.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10 LEXICON PHARMACEUTICALS, INC

14.10.1   Key Facts

14.10.2   Business Description

14.10.3   Products and Services

14.10.4   Financial Overview

14.10.5   SWOT Analysis

14.10.6   Key Developments

15.          Appendix

15.1    Glossary of Terms

LIST OF TABLES

Table 1.             North America Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 5.             US Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 6.             US Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.             US Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 8.             US Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             Canada Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          Canada Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 11.          Canada Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Mexico Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 14.          Mexico Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 15.          Mexico Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          Europe Gastrointestinal Drugs Market, by Drug Class– Revenue and Forecast to 2027 (USD Million)

Table 18.          Europe Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 19.          Europe Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 20.          Europe Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Germany Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 22.          Germany Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 23.          Germany Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 24.          Germany Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          UK Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 26.          UK Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 27.          UK Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 28.          UK Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 29.          France Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 30.          France Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 31.          France Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 32.          France Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 33.          Spain Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 34.          Spain Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 35.          Spain Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 36.          Spain Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 37.          Italy Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 38.          Italy Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 39.          Italy Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 40.          Italy Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 41.          Rest of Europe Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 42.          Rest of Europe Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 43.          Rest of Europe Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 44.          Rest of Europe Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 45.          Asia Pacific Gastrointestinal Drugs Market, by Drug Class– Revenue and Forecast to 2027 (USD Million)

Table 46.          Asia Pacific Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 47.          Asia Pacific Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 48.          Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 49.          China Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 50.          China Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 51.          China Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 52.          China Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 53.          Japan Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 54.          Japan Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 55.          Japan Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 56.          Japan Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 57.          India Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 58.          India Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 59.          India Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 60.          India Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 61.          South Korea Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 62.          South Korea Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 63.          South Korea Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 64.          South Korea Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 65.          Australia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 66.          Australia Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 67.          Australia Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 68.          Australia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 69.          Rest of Asia-Pacific Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027  (USD Million)

Table 70.          Rest of Asia-Pacific Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 71.          Rest of Asia-Pacific Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027  (USD Million)

Table 72.          Rest of Asia-Pacific Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 73.          Middle East & Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027  (USD Million)

Table 74.          Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 75.          Middle East & Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027  (USD Million)

Table 76.          Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 77.          Saudi Arabia Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 78.          Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027  (USD Million)

Table 79.          Saudi Arabia Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 80.          Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 81.          UAE Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 82.          UAE Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 83.          UAE Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 84.          UAE Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 85.          South Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 86.          South Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027  (USD Million)

Table 87.          South Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 88.          South Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 89.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 90.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 91.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 92.          Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 93.          South and Central America: Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027  (USD Million)

Table 94.          South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 95.          South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 96.          South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 97.          Brazil: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 98.          Brazil: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 99.          Brazil: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 100.       Brazil: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 101.       Argentina: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 102.       Argentina: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 103.       Argentina: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 104.       Argentina: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 105.       Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 106.       Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 107.       Rest of South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 108.       Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 1.             Organic Developments Done By Companies

Table 2.             Inorganic Developments Done By Companies

Table 3.             Glossary of Terms, Gastrointestinal Drugs Market

 

LIST OF FIGURES

Figure 1.           Gastrointestinal Drugs Market Segmentation

Figure 2.           Gastrointestinal Drugs Market – By Geography

Figure 3.           Gastrointestinal Drugs Market Overview

Figure 4.           Acid Neutralizers Segment Held Largest Share of Gastrointestinal Drugs Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           Gastrointestinal Drugs Market, by Geography (US$ Million)

Figure 7.           Global Gastrointestinal Drugs Market – Leading Country Markets (US$ Million)

Figure 8.           Global Gastrointestinal Drugs Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint

Figure 15.        Global Gastrointestinal Drugs Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16.        Global Gastrointestinal Drugs Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Gastrointestinal Drugs Market

Figure 18.        Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)

Figure 19.        Acid Neutralizers: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Antidiarrheal and Laxatives: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Anti-Inflammatory Drugs: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Antiemetic and Antinauseants: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Biologics: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027

Figure 26.        Oral: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Parenteral: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)

Figure 29.        Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Crohn's Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Irritable Bowel Syndrome: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Gastroenteritis: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Celiac Disease: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Others: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027

Figure 36.        Hospital Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        Retail Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 38.        Online Pharmacies: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (US$ Million)

Figure 39.        North America: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 40.        North America Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 41.        North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

Figure 42.        US: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Canada: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Mexico: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 45.        Europe: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 46.        Europe Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 47.        Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)

Figure 48.        Germany: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        UK: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        France: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        Spain: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 52.        Italy: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 53.        Rest of Europe: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        Asia Pacific: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 55.        Asia Pacific Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 56.        China: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Japan: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        India: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 59.        South Korea: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 60.        Australia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 61.        Rest of Asia-Pacific: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 62.        Middle East & Africa: Gastrointestinal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 63.        Middle East & Africa Gastrointestinal Drugs Market Revenue and Forecast to 2027 (USD Million)

Figure 64.        Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

Figure 65.        Saudi Arabia: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 66.        UAE: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        South Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)

Figure 68.        Rest of Middle East and Africa Gastrointestinal drugs market Revenue and Forecasts to 2027 (US$ Mn)

Figure 69.        South and Central America: Gastrointestinal Drugs Market , by Key Country – Revenue (2019) (USD Million)

Figure 70.        South and Central America: Gastrointestinal Drugs Market, Revenue and Forecast to 2027 (USD Million)

Figure 71.        South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

Figure 72.        Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 73.        Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 74.        Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027  (USD Million)

Figure 75.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in North American Countries

Figure 76.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in European Countries

Figure 77.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Asia Pacific Countries

Figure 78.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Rest of the World

Figure 79.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Gastrointestinal Drugs Market

  1. Sanofi
  2. GlaxoSmithKline plc
  3. Johnson and Johnson Services, Inc.
  4. Bausch Health
  5. AstraZeneca
  6. Takeda Pharmaceutical Company Limited
  7. AbbVie Inc.
  8. Bayer AG
  9. Celltrion Healthcare Co.,Ltd
  10. LEXICON PHARMACEUTICALS, INC

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastrointestinal drugs market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00014758
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing